Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,686 | 13,277 | 36,953 | 38,444 | 28,138 |
| Marketable Securities | 47,659 | 89,814 | 147,620 | 118,835 | 203,828 |
| Receivables | 3,026 | 405 | 2,515 | 70,699 | 7,144 |
| Other current assets | 1,443 | 0 | 0 | 0 | 0 |
| TOTAL | $63,727 | $105,205 | $189,583 | $231,255 | $240,810 |
| Non-Current Assets | |||||
| PPE Net | 623 | 3,275 | 4,471 | 4,825 | 5,104 |
| Other Non-Current Assets | 728 | 1,842 | 1,428 | 1,807 | 1,928 |
| TOTAL | $1,351 | $5,117 | $5,899 | $6,632 | $7,032 |
| Total Assets | $65,078 | $110,322 | $195,482 | $237,887 | $247,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,787 | 2,565 | 4,890 | 6,660 | 4,448 |
| Accrued Expenses | 7,104 | 8,374 | 30,453 | 23,696 | 14,663 |
| Other current liabilities | N/A | N/A | N/A | 4 | 10 |
| TOTAL | $12,644 | $93,132 | $55,853 | $52,641 | $38,546 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,753 | 82,193 | 20,510 | 22,281 | 19,425 |
| Other Non-Current Liabilities | 100 | 383 | 367 | 354 | 338 |
| TOTAL | $4,203 | $65,793 | $162,657 | $181,695 | $132,929 |
| Total Liabilities | $16,847 | $158,925 | $218,510 | $234,336 | $171,475 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,690 | 38,260 | 37,398 | 30,276 | 29,942 |
| Common Shares | 38 | 38 | 37 | 30 | 30 |
| Retained earnings | -361,786 | -452,007 | -412,945 | -309,843 | -224,436 |
| Other shareholders' equity | -29 | 289 | 260 | 20 | -17 |
| TOTAL | $48,231 | $-48,603 | $-23,028 | $3,551 | $76,367 |
| Total Liabilities And Equity | $65,078 | $110,322 | $195,482 | $237,887 | $247,842 |